HOPE STEINFORTH: Open Payments
NPI 1497443394 · LOUISVILLE, KY. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$3,177 in 134 payments from 20 companies in 2025. Trend: 2023 $1,058 · 2024 $1,712 · 2025 $3,177
Food & beverage: $3,018Education: $159
| Company | Payments | Amount |
|---|---|---|
| SUN PHARMACEUTICAL INDUSTRIES INC. | 22 | $751 |
| Janssen Biotech, Inc. | 19 | $603 |
| Arcutis Biotherapeutics, Inc. | 11 | $364 |
| ABBVIE INC. | 22 | $215 |
| Amgen Inc. | 6 | $194 |
| Lilly USA, LLC | 10 | $187 |
| GENZYME CORPORATION | 10 | $182 |
| UCB, Inc. | 8 | $156 |
| LEO Pharma Inc. | 4 | $101 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 4 | $93 |
Products named: ILUMYA, TREMFYA, DUPIXENT, Zoryve, OTEZLA, Bimzelx, TALTZ, SKYRIZI.
Industry payments across KY — which companies pay providers there.
